Elaine Chiquette
Nessuna posizione attualmente
Profilo
Elaine Chiquette served as the Chief Scientific Officer at Gelesis, Inc. from 2017 to 2022, and at Gelesis Holdings, Inc. from 2022 to 2023.
Prior to her work at Gelesis, she earned an undergraduate degree from Université Laval and a doctorate from the University of Texas Health Science Center At San Antonio.
Precedenti posizioni note di Elaine Chiquette
| Società | Posizione | Fine |
|---|---|---|
| GELESIS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 30/10/2023 |
| GELESIS INC | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
Formazione di Elaine Chiquette
| Université Laval | Undergraduate Degree |
| University of Texas Health Science Center At San Antonio | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Elaine Chiquette
